Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Robert Keith

Concepts (301)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Lung Neoplasms
54
2024
2489
5.390
 Why?
Precancerous Conditions
11
2024
169
2.760
 Why?
Epoprostenol
12
2021
136
2.130
 Why?
Carcinoma, Squamous Cell
11
2023
683
2.120
 Why?
Chemoprevention
8
2023
92
1.860
 Why?
Cancer Survivors
4
2023
280
1.760
 Why?
Iloprost
10
2023
45
1.610
 Why?
Carcinoma, Non-Small-Cell Lung
10
2024
1076
1.600
 Why?
Carmustine
3
2020
50
1.530
 Why?
Smoke
4
2020
140
1.330
 Why?
Bronchi
10
2018
260
1.290
 Why?
Intramolecular Oxidoreductases
8
2018
68
1.210
 Why?
Cytochrome P-450 Enzyme System
8
2018
155
1.160
 Why?
Smoking
16
2019
1620
0.950
 Why?
Telerehabilitation
1
2023
37
0.800
 Why?
Carcinoma in Situ
5
2019
49
0.780
 Why?
Leisure Activities
1
2021
32
0.700
 Why?
Lung
16
2023
4061
0.680
 Why?
Antineoplastic Agents
7
2013
2123
0.630
 Why?
Respiratory System
1
2020
157
0.620
 Why?
Disease Models, Animal
6
2022
4281
0.600
 Why?
Carcinogens
6
2022
124
0.590
 Why?
Frizzled Receptors
2
2016
25
0.590
 Why?
Biomarkers, Tumor
9
2015
1272
0.570
 Why?
Tobacco Smoke Pollution
1
2020
261
0.560
 Why?
Neoplasms, Experimental
2
2018
176
0.550
 Why?
Pulmonary Disease, Chronic Obstructive
7
2020
1036
0.550
 Why?
Bronchial Neoplasms
3
2011
15
0.520
 Why?
Urethane
4
2022
43
0.510
 Why?
Mice
24
2023
17758
0.490
 Why?
Hospitalists
1
2020
245
0.480
 Why?
Antihypertensive Agents
2
2017
488
0.480
 Why?
PPAR gamma
3
2022
182
0.470
 Why?
Sputum
8
2019
311
0.460
 Why?
Bronchopulmonary Dysplasia
1
2019
382
0.440
 Why?
Telemedicine
1
2023
852
0.440
 Why?
Animals
29
2023
36836
0.420
 Why?
Trachea
1
2015
237
0.410
 Why?
Quality of Life
4
2023
2876
0.410
 Why?
Mice, Transgenic
9
2018
2163
0.400
 Why?
Bronchoscopy
7
2019
222
0.380
 Why?
MicroRNAs
2
2016
692
0.380
 Why?
Adenocarcinoma
3
2017
938
0.380
 Why?
Practice Guidelines as Topic
1
2020
1569
0.370
 Why?
Hyperplasia
2
2011
175
0.360
 Why?
Biopsy
10
2023
1124
0.360
 Why?
Cell Transformation, Neoplastic
4
2023
327
0.350
 Why?
Humans
54
2024
136750
0.330
 Why?
Vasodilator Agents
2
2011
331
0.330
 Why?
Exercise
1
2021
2044
0.310
 Why?
Receptors, Epoprostenol
1
2008
6
0.300
 Why?
Epithelial-Mesenchymal Transition
2
2022
209
0.300
 Why?
Quinazolines
1
2010
250
0.290
 Why?
Gene Expression Regulation
2
2016
2605
0.290
 Why?
Lung Diseases, Obstructive
1
2007
50
0.270
 Why?
Receptors, Prostaglandin E
1
2006
7
0.260
 Why?
Dinoprostone
5
2010
191
0.240
 Why?
Neovascularization, Pathologic
4
2015
301
0.240
 Why?
Desmoglein 3
2
2022
15
0.240
 Why?
Biomedical Research
1
2011
688
0.230
 Why?
Female
24
2022
72785
0.230
 Why?
Disease Progression
7
2024
2751
0.220
 Why?
Protein Kinase Inhibitors
1
2010
916
0.210
 Why?
Chromosome Aberrations
4
2013
155
0.210
 Why?
Adrenal Cortex Hormones
1
2007
556
0.200
 Why?
Drug Evaluation, Preclinical
2
2017
184
0.200
 Why?
Anticarcinogenic Agents
2
2018
77
0.200
 Why?
Clinical Trials as Topic
3
2013
1044
0.190
 Why?
Risk Factors
7
2021
10330
0.190
 Why?
Keratin-5
1
2022
50
0.190
 Why?
Formaldehyde
1
2022
63
0.190
 Why?
Mice, Inbred A
2
2020
49
0.190
 Why?
Cross-Sectional Studies
4
2021
5419
0.190
 Why?
Butylated Hydroxytoluene
4
2006
38
0.190
 Why?
Smokers
2
2019
145
0.180
 Why?
Confidence Intervals
2
2021
328
0.180
 Why?
Tubulin
1
2022
140
0.180
 Why?
Placebos
2
2019
199
0.180
 Why?
Behavioral Risk Factor Surveillance System
1
2021
51
0.180
 Why?
Double-Blind Method
2
2019
1982
0.170
 Why?
United States
4
2024
14682
0.170
 Why?
Respiratory Mucosa
3
2015
322
0.170
 Why?
Middle Aged
20
2021
33225
0.170
 Why?
Neoplasm Invasiveness
6
2015
507
0.170
 Why?
Aged
18
2021
23800
0.170
 Why?
Societies, Medical
1
2024
816
0.160
 Why?
Male
27
2021
67305
0.160
 Why?
Carcinogenesis
1
2021
217
0.160
 Why?
Epithelial Cells
4
2018
1094
0.160
 Why?
Air Pollution
1
2023
315
0.160
 Why?
Ki-67 Antigen
4
2015
111
0.150
 Why?
Lung Diseases
3
2015
768
0.150
 Why?
ErbB Receptors
3
2023
613
0.150
 Why?
United Kingdom
1
2020
310
0.150
 Why?
Remission Induction
1
2019
288
0.150
 Why?
Rats
5
2010
5639
0.150
 Why?
Pulmonary Emphysema
3
2007
288
0.140
 Why?
Air Pollutants
1
2023
427
0.140
 Why?
Receptors, Prostaglandin
1
2017
22
0.140
 Why?
Mice, Inbred BALB C
3
2011
1269
0.140
 Why?
Receptors, G-Protein-Coupled
2
2010
220
0.140
 Why?
Biological Availability
1
2017
148
0.140
 Why?
Receptors, CXCR4
1
2017
86
0.130
 Why?
RNA, Messenger
3
2022
2831
0.130
 Why?
Self Report
1
2021
822
0.130
 Why?
Socioeconomic Factors
1
2021
1282
0.130
 Why?
Chromosomal Instability
2
2013
19
0.120
 Why?
Health Status
1
2021
788
0.120
 Why?
In Situ Hybridization, Fluorescence
4
2010
317
0.120
 Why?
Logistic Models
1
2021
2067
0.120
 Why?
Mitotic Index
1
2015
25
0.120
 Why?
Smoking Cessation
1
2019
436
0.120
 Why?
Signal Transduction
5
2013
5077
0.120
 Why?
Sensitivity and Specificity
7
2010
1936
0.110
 Why?
Phospholipases A
2
2006
102
0.110
 Why?
Macrophages, Alveolar
3
2023
391
0.110
 Why?
Methylcholanthrene
2
2006
22
0.110
 Why?
Mental Health
1
2021
716
0.110
 Why?
Cell Proliferation
3
2018
2476
0.110
 Why?
Neoplasm Grading
1
2015
305
0.110
 Why?
Macrophages
2
2020
1544
0.110
 Why?
Microarray Analysis
1
2013
116
0.110
 Why?
Stem Cells
1
2018
592
0.100
 Why?
Tertiary Prevention
1
2013
3
0.100
 Why?
Immunoenzyme Techniques
2
2011
219
0.100
 Why?
Inflammation
3
2018
2835
0.100
 Why?
Treatment Outcome
4
2018
10747
0.100
 Why?
Pulmonary Alveoli
2
2006
405
0.100
 Why?
Secondary Prevention
1
2013
233
0.090
 Why?
Administration, Topical
1
2011
149
0.090
 Why?
Primary Prevention
1
2013
196
0.090
 Why?
Cell Line, Tumor
2
2017
3406
0.090
 Why?
Time Factors
2
2021
6808
0.090
 Why?
Immunohistochemistry
5
2015
1733
0.080
 Why?
Cells, Cultured
2
2016
4192
0.080
 Why?
Tumor Cells, Cultured
2
2010
953
0.080
 Why?
Biomarkers
4
2023
4145
0.080
 Why?
Isotretinoin
1
2009
26
0.080
 Why?
Tocopherols
1
2009
26
0.080
 Why?
Surveys and Questionnaires
1
2021
5739
0.080
 Why?
Neoplasms, Glandular and Epithelial
1
2009
49
0.070
 Why?
rho GTP-Binding Proteins
1
2009
60
0.070
 Why?
Gene Expression Regulation, Neoplastic
3
2018
1396
0.070
 Why?
Cadherins
1
2010
205
0.070
 Why?
Oligonucleotide Array Sequence Analysis
3
2005
766
0.070
 Why?
Glycoproteins
1
2010
342
0.070
 Why?
6-Ketoprostaglandin F1 alpha
2
2004
21
0.070
 Why?
Spectral Karyotyping
1
2007
5
0.070
 Why?
Adenoma
1
2010
230
0.070
 Why?
Loss of Heterozygosity
2
2013
51
0.070
 Why?
Endothelium, Vascular
2
2007
926
0.070
 Why?
Acrolein
1
2007
23
0.070
 Why?
Cytosol
2
2006
226
0.070
 Why?
Survival Rate
1
2011
1962
0.070
 Why?
Phagocytosis
1
2009
379
0.070
 Why?
Genome-Wide Association Study
1
2013
1428
0.070
 Why?
Receptors, Prostaglandin E, EP2 Subtype
1
2006
6
0.060
 Why?
Cell Growth Processes
1
2006
52
0.060
 Why?
Amiodarone
1
2006
26
0.060
 Why?
Follow-Up Studies
2
2015
5105
0.060
 Why?
Polymorphism, Single Nucleotide
1
2013
2184
0.060
 Why?
Anti-Arrhythmia Agents
1
2006
114
0.060
 Why?
Periodontal Diseases
1
2006
60
0.060
 Why?
Mice, Knockout
3
2009
3009
0.060
 Why?
Administration, Inhalation
1
2007
683
0.060
 Why?
Leukocytes
1
2006
311
0.060
 Why?
Mice, Inbred C57BL
4
2008
5750
0.050
 Why?
Aged, 80 and over
7
2015
7593
0.050
 Why?
Receptor, ErbB-2
1
2006
340
0.050
 Why?
Bronchiolitis
1
2004
80
0.050
 Why?
Case-Control Studies
5
2012
3540
0.050
 Why?
Pulmonary Embolism
1
2006
225
0.050
 Why?
Genotype
1
2008
1914
0.050
 Why?
Bronchoalveolar Lavage Fluid
2
2006
654
0.050
 Why?
Carcinoma, Bronchogenic
1
2002
20
0.050
 Why?
Tomography, Spiral Computed
1
2002
32
0.050
 Why?
Patient Compliance
1
2007
577
0.050
 Why?
Apoptosis
2
2009
2552
0.050
 Why?
Muscles
1
2023
325
0.050
 Why?
Pulmonary Artery
2
2005
1085
0.050
 Why?
Vascular Endothelial Growth Factor A
1
2005
543
0.050
 Why?
Antioxidants
2
2006
584
0.050
 Why?
Alveolar Epithelial Cells
1
2023
114
0.050
 Why?
Particle Size
1
2023
391
0.050
 Why?
Dyspnea
1
2023
252
0.050
 Why?
Hemorrhage
1
2006
720
0.040
 Why?
Gene Expression Profiling
2
2005
1772
0.040
 Why?
Neoplasm Proteins
1
2004
434
0.040
 Why?
Weight Gain
1
2004
519
0.040
 Why?
Cell Line
2
2018
2838
0.040
 Why?
Research Design
1
2007
1127
0.040
 Why?
Particulate Matter
1
2023
312
0.040
 Why?
Chromosomes, Human, Pair 3
1
2000
50
0.040
 Why?
Platelet Endothelial Cell Adhesion Molecule-1
1
2000
52
0.040
 Why?
Prevalence
2
2023
2708
0.040
 Why?
Reverse Transcriptase Polymerase Chain Reaction
3
2010
975
0.040
 Why?
Tuberculosis
1
2003
279
0.040
 Why?
Survivors
1
2023
487
0.040
 Why?
Cell Cycle Proteins
2
2018
613
0.040
 Why?
Sepsis
1
2006
614
0.040
 Why?
Cohort Studies
2
2023
5703
0.040
 Why?
Enzyme Inhibitors
1
2022
839
0.040
 Why?
gamma Catenin
1
2018
13
0.040
 Why?
Walking
1
2023
523
0.040
 Why?
Metaplasia
1
2018
60
0.040
 Why?
Tobacco Smoking
1
2018
25
0.040
 Why?
Bronchial Diseases
1
2018
37
0.040
 Why?
Cell Division
1
2000
796
0.040
 Why?
Antineoplastic Combined Chemotherapy Protocols
1
2007
1684
0.040
 Why?
Environmental Exposure
1
2023
572
0.040
 Why?
Pilot Projects
1
2023
1693
0.040
 Why?
Time
1
2018
82
0.040
 Why?
Cell Cycle Checkpoints
1
2018
98
0.040
 Why?
ROC Curve
2
2010
544
0.030
 Why?
Prognosis
1
2006
4012
0.030
 Why?
Epithelium
1
2018
311
0.030
 Why?
Genetic Predisposition to Disease
1
2005
2412
0.030
 Why?
Tumor Suppressor Protein p53
1
2000
528
0.030
 Why?
Adult
7
2018
37626
0.030
 Why?
Hypoxia
1
2003
1112
0.030
 Why?
Prospective Studies
2
2023
7572
0.030
 Why?
Phospholipases A2
2
2006
80
0.030
 Why?
Neoplasm Staging
2
2010
1373
0.030
 Why?
Proto-Oncogene Proteins
1
2018
647
0.030
 Why?
Mass Screening
1
2002
1266
0.030
 Why?
Endoscopy
1
2015
318
0.020
 Why?
Risk
2
2007
908
0.020
 Why?
Veterans
1
2002
1466
0.020
 Why?
Administration, Oral
1
2012
812
0.020
 Why?
Incidence
2
2010
2797
0.020
 Why?
Severity of Illness Index
1
2018
2819
0.020
 Why?
Luciferases
1
2010
149
0.020
 Why?
Area Under Curve
1
2010
314
0.020
 Why?
International Agencies
1
2009
35
0.020
 Why?
Mice, Inbred ICR
1
2009
119
0.020
 Why?
Mutation
1
2000
3947
0.020
 Why?
rhoA GTP-Binding Protein
1
2009
86
0.020
 Why?
Fluorescence
1
2009
160
0.020
 Why?
rho-Associated Kinases
1
2009
83
0.020
 Why?
Cytotoxins
1
2007
16
0.020
 Why?
Platinum
1
2007
49
0.020
 Why?
Blotting, Western
1
2010
1225
0.020
 Why?
Carboplatin
1
2007
142
0.020
 Why?
Airway Obstruction
1
2009
162
0.020
 Why?
Bevacizumab
1
2007
135
0.020
 Why?
Intracellular Signaling Peptides and Proteins
1
2010
455
0.020
 Why?
Minichromosome Maintenance Complex Component 2
1
2006
4
0.020
 Why?
Chemokine CCL8
1
2006
3
0.020
 Why?
Paclitaxel
1
2007
227
0.020
 Why?
Monocyte Chemoattractant Proteins
1
2006
8
0.020
 Why?
Databases, Nucleic Acid
1
2005
34
0.020
 Why?
Angiogenesis Inhibitors
1
2007
226
0.020
 Why?
Chemokine CCL2
1
2006
115
0.020
 Why?
Enzymes
1
2005
67
0.010
 Why?
Receptors, Vascular Endothelial Growth Factor
1
2005
108
0.010
 Why?
Species Specificity
1
2005
586
0.010
 Why?
Cell Culture Techniques
1
2007
362
0.010
 Why?
Microsomes
1
2004
33
0.010
 Why?
Cyclooxygenase 1
1
2004
27
0.010
 Why?
Tomography, X-Ray Computed
2
2006
2666
0.010
 Why?
Cluster Analysis
1
2005
497
0.010
 Why?
Tachycardia, Ventricular
1
2006
175
0.010
 Why?
Prostaglandin-Endoperoxide Synthases
1
2004
77
0.010
 Why?
Prostaglandins
1
2004
97
0.010
 Why?
DNA Replication
1
2005
238
0.010
 Why?
Arachidonic Acid
1
2004
120
0.010
 Why?
Tumor Necrosis Factor-alpha
1
2009
1242
0.010
 Why?
Immunoblotting
1
2004
306
0.010
 Why?
Predictive Value of Tests
1
2009
2021
0.010
 Why?
Cyclooxygenase 2
1
2004
178
0.010
 Why?
Isoenzymes
1
2004
304
0.010
 Why?
Vital Capacity
1
2004
309
0.010
 Why?
Neutrophils
1
2009
1236
0.010
 Why?
Evidence-Based Medicine
1
2007
739
0.010
 Why?
Osteopontin
1
2003
33
0.010
 Why?
Neoplasm Recurrence, Local
1
2009
1058
0.010
 Why?
Solitary Pulmonary Nodule
1
2002
21
0.010
 Why?
Sialoglycoproteins
1
2003
159
0.010
 Why?
Enzyme-Linked Immunosorbent Assay
1
2005
851
0.010
 Why?
Forced Expiratory Volume
1
2004
531
0.010
 Why?
Drainage
1
2003
171
0.010
 Why?
Oxidative Stress
1
2009
1314
0.010
 Why?
Up-Regulation
1
2005
844
0.010
 Why?
Antibodies, Monoclonal, Humanized
1
2007
801
0.010
 Why?
Sex Factors
1
2007
2064
0.010
 Why?
Hospitals, Veterans
1
2002
249
0.010
 Why?
Atrial Fibrillation
1
2006
387
0.010
 Why?
Endothelial Cells
1
2007
778
0.010
 Why?
Radiation Dosage
1
2002
175
0.010
 Why?
Nuclear Proteins
1
2006
712
0.010
 Why?
Alleles
1
2004
890
0.010
 Why?
Lipid Metabolism
1
2004
512
0.010
 Why?
Antibodies, Monoclonal
1
2007
1430
0.010
 Why?
Feasibility Studies
1
2002
949
0.010
 Why?
RNA
1
2005
921
0.010
 Why?
Membrane Proteins
1
2004
1163
0.010
 Why?
Rats, Sprague-Dawley
1
2003
2486
0.010
 Why?
Risk Assessment
1
2004
3432
0.010
 Why?
Colorado
1
2002
4512
0.010
 Why?
Hypertension, Pulmonary
1
2003
1904
0.010
 Why?
Retrospective Studies
1
2005
15499
0.000
 Why?
Keith's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (301) concept(s)
_
Co-Authors Expand Description
See all (45) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)